Elcys (Cysteine HCl) Patent Expiration, LOE Window & CMS Spending

Elcys (Cysteine HCl) by Exela Sciences: FDA Orange Book LOE 2039-01-15, 0 AB generics, $1.7M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorExela Sciences
FDA Application & PathwayN210660 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2039-01-15
Orange Book Patents (*PED Extensions)16 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$1.7M
2024 Medicare Part D Spend$0
2024 Medicaid Spend$1.7M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 26.3% 2-yr change)